DK0464105T3 - Melaninkoncentrerende hormoner og DNA til ekspression af samme - Google Patents

Melaninkoncentrerende hormoner og DNA til ekspression af samme

Info

Publication number
DK0464105T3
DK0464105T3 DK90905279.7T DK90905279T DK0464105T3 DK 0464105 T3 DK0464105 T3 DK 0464105T3 DK 90905279 T DK90905279 T DK 90905279T DK 0464105 T3 DK0464105 T3 DK 0464105T3
Authority
DK
Denmark
Prior art keywords
mch
glu
peptides
ala
rat
Prior art date
Application number
DK90905279.7T
Other languages
English (en)
Inventor
Wylie Walker Vale Jr
Wolfgang Hermann Fischer
Jean Edouard Rivier
Joan Vaughan
Jean-Louis Marie Nahon
Francoise Genevieve Presse
Original Assignee
Salk Inst For Biological Studi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salk Inst For Biological Studi filed Critical Salk Inst For Biological Studi
Application granted granted Critical
Publication of DK0464105T3 publication Critical patent/DK0464105T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/854—Glands

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK90905279.7T 1989-03-22 1990-03-20 Melaninkoncentrerende hormoner og DNA til ekspression af samme DK0464105T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/326,984 US5049655A (en) 1989-03-22 1989-03-22 Melanin-concentrating hormones

Publications (1)

Publication Number Publication Date
DK0464105T3 true DK0464105T3 (da) 1997-01-06

Family

ID=23274624

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90905279.7T DK0464105T3 (da) 1989-03-22 1990-03-20 Melaninkoncentrerende hormoner og DNA til ekspression af samme

Country Status (8)

Country Link
US (3) US5049655A (da)
EP (1) EP0464105B1 (da)
JP (1) JP2944202B2 (da)
AT (1) ATE141288T1 (da)
CA (1) CA2046900C (da)
DE (1) DE69028101T2 (da)
DK (1) DK0464105T3 (da)
WO (1) WO1990011295A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849708A (en) * 1995-06-06 1998-12-15 Joslin Diabetes Center, Inc. Promotion of eating behavior
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
AU1802000A (en) * 1998-12-28 2000-07-24 Takeda Chemical Industries Ltd. Screening method
GB9924351D0 (en) 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
US7220720B2 (en) * 2000-02-03 2007-05-22 Merk & Co., Inc. Melanin-concentrating hormone analogs
WO2001057070A1 (en) * 2000-02-03 2001-08-09 Merck & Co., Inc. Melanin-concentrating hormone analogs
US20070135425A1 (en) * 2001-05-04 2007-06-14 Amgen Inc. Fused heterocyclic compounds
US6809104B2 (en) * 2001-05-04 2004-10-26 Tularik Inc. Fused heterocyclic compounds
GB0112343D0 (en) * 2001-05-21 2001-07-11 Norske Stats Oljeselskap Well treatment
US7314861B2 (en) * 2001-05-31 2008-01-01 Merck & Co., Inc. Melanin-concentrating hormone analogs
JP2004537581A (ja) * 2001-08-08 2004-12-16 メルク　エンド　カムパニー　インコーポレーテッド メラニン濃縮ホルモン拮抗物質
JP2005527491A (ja) * 2002-01-09 2005-09-15 メルク　エンド　カムパニー　インコーポレーテッド 選択的メラニン凝集ホルモンタイプ−１受容体アゴニスト
KR20030066187A (ko) * 2002-02-05 2003-08-09 나드리화장품주식회사 미백 화장료 조성물
KR20050103184A (ko) * 2002-11-06 2005-10-27 암젠 인코포레이션 융합된 헤테로사이클릭 화합물들
BRPI0512142B1 (pt) 2004-06-17 2018-01-23 Statoil Petroleum As Método para o tratamento de uma formação subterrânea, uso de um material, e, composição de tratamento de poço de hidrocarboneto
WO2005124099A1 (en) * 2004-06-17 2005-12-29 Statoil Asa Well treatment
BRPI0609877A2 (pt) * 2005-04-26 2010-05-11 Statoilhydro Asa processo de tratamento e construção de poços
KR100839194B1 (ko) 2006-12-14 2008-06-17 부경대학교 산학협력단 양식 넙치의 멜라닌농축호르몬
GB2450502B (en) * 2007-06-26 2012-03-07 Statoil Asa Microbial enhanced oil recovery
WO2009043523A2 (en) * 2007-09-11 2009-04-09 Mondobiotech Laboratories Ag Cortistatin 17 and neuropeptide 1 for use as therapeutic agent
EP2187901B1 (en) * 2007-09-11 2012-08-08 Mondobiotech Laboratories AG Neuropeptide El optionally combined with ACTH (7-38) for use in anti-angiogenic therapy

Also Published As

Publication number Publication date
JP2944202B2 (ja) 1999-08-30
EP0464105A4 (en) 1992-08-12
EP0464105B1 (en) 1996-08-14
US5449766A (en) 1995-09-12
EP0464105A1 (en) 1992-01-08
JPH04503812A (ja) 1992-07-09
DE69028101D1 (de) 1996-09-19
US5530095A (en) 1996-06-25
CA2046900A1 (en) 1990-09-23
US5049655A (en) 1991-09-17
ATE141288T1 (de) 1996-08-15
CA2046900C (en) 2000-08-22
WO1990011295A1 (en) 1990-10-04
DE69028101T2 (de) 1997-03-06

Similar Documents

Publication Publication Date Title
DK0464105T3 (da) Melaninkoncentrerende hormoner og DNA til ekspression af samme
Wang et al. Purification and characterization of other distinct bone-inducing factors.
Kangawa et al. Structural identification of β-and γ-human atrial natriuretic polypeptides
Thomas et al. Pure brain-derived acidic fibroblast growth factor is a potent angiogenic vascular endothelial cell mitogen with sequence homology to interleukin 1.
Goldstein et al. Thymosins: chemistry and biological properties in health and disease
Prinz et al. T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted products
CHOCHINOV et al. Characterization of a protein in mid-term human amniotic fluid which reacts in the somatomedin-C radioreceptor assay
ES2426420T3 (es) Péptidos de queratina bioactivos
Lernhardt et al. T-cell hybridomas which produce B lymphocyte replication factors only
US4508712A (en) Atrial peptide
KR960007604B1 (ko) 인체 렐락신 또는 그 유사체를 제조하는 방법
US7008925B1 (en) Melanocortin 1 receptor selective compounds
JPH075481B2 (ja) 創傷の治癒
EP0617126A3 (en) Polypeptide capable of inhibiting the binding between human IL-6 and its receptor.
GB2304047A (en) Pharmaceutical compositions containing cytokines
FI842166A (fi) Bukspottskoertelns grf hos maenniskan.
JPH06329549A (ja) インターロイキン１２のｐ４０サブユニットを含んでなる医薬
KR100424553B1 (ko) 사람인터루킨-6억제제
CA2566776C (en) Method for ameliorating an inflammatory skin condition
ES2173856T3 (es) Proceso para la preparacion de vectores geneticos para la expresion del factor de crecimiento nervioso en celulas eucariotas.
KR920004571A (ko) 헤파린 결합 향신경성 인자(hbnf)를 암호하는 유전자, 이를 포함하는 발현 벡터 및 숙주 세포, 및 hbnf의 생성 방법 및 사용방법
TAKAOKA et al. Purification and characterization of a bone-inducing protein from a murine osteosarcoma (Dunn type)
MXPA01011158A (es) Factor de crecimiento homologo zvegf4.
JPH03500529A (ja) 増殖因子
Vaughan et al. DNA encoding NEI and NGE peptides